Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Summary
This is a prospective, single-arm, open-label, dose-exploration and expansion clinical study of LCAR-AIO in adult subjects with relapsed/refractory systemic lupus erythematosus.
Official title: An Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LCAR-AIO for the Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
34
Start Date
2025-01-08
Completion Date
2029-09-30
Last Updated
2025-01-10
Healthy Volunteers
No
Conditions
Interventions
LCAR-AIO T cells
Before treatment with LCAR-AIO T cells, subjects will receive a conditioning regimen.
Locations (1)
Wuhan Union Hospital
Wuhan, Hubei, China